MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair...

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Charcot-Marie-Tooth disease (CMT) type 2A is a peripheral neuropathy linked to mutations in the mitofusin-2 (MFN2) gene.
• MFN2 protein is crucial for mitochondrial fusion and endoplasmic reticulum (ER)-mitochondrial tethering at mitochondria-associated ER membranes (MAM).
• The impact of MFN2 mutations on MAM function in CMT2A remains unexplored.

Purpose of the Study:

• To investigate whether MFN2 mutations in CMT2A patient cells alter MAM function.
• To correlate observed changes in MAM function with disease severity and genotype.
• To determine if respiratory chain function is affected in CMT2A patient cells.

Main Methods:

• Fibroblast cell cultures were established from three CMT2A patients with distinct MFN2 mutations.
• ER-mitochondrial connectivity and MAM function were assessed in patient-derived fibroblasts.
• Respiratory chain function was evaluated in the same cell lines.

Main Results:

• Alterations in ER-mitochondrial connectivity and MAM function were observed in some CMT2A patient cells, correlating with disease severity.
• Respiratory chain function remained unimpaired in all examined patient cells.
• The findings indicate that MFN2 mutations impact MAM function but not mitochondrial respiration.

Conclusions:

• CMT2A is characterized by impaired mitochondria-associated ER membrane (MAM) function, suggesting it is a MAM-related disorder.
• The disease is not a result of respiratory chain deficiency.
• These findings provide insights into CMT2A pathogenesis and potentially other forms of CMT.